■ 영문제목 : Animal Antibiotics and Antimicrobials Marketby Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Inmixes, Oral Sol
■ 상품코드 : PH2458K ■ 조사 / 발행사 : Markets and Markets ■ 발행일 : 2021년 3월 ■ 쪽수 : 248 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : 이메일 ■ 조사 대상 지역 : 글로벌 ■ 산업 분야 : 제약 Markets and Markets and Markets사는 세계 동물용 항생제 및 항균제 및 항균제 형태 : PDF ■ 납품 방식 본 조사연구에서는 전 세계 동물용 항생제 및 항균제 시장을 광범위하게 조사, 소개, 조사방법, 개요, 프리미엄 인사이트, 시장개요, 산업인사이트, 제품별(테트라사이클린, 페니실린, 술파제, 마크로라이드, 아미노글리코시드) 분석, 전달방식별(프리믹스, 경구분말, 주사 기타) 분석, 동물 종류별(식량생산 동물, 페니실린, 마크로라이드, 펫트릭스에 관한 정보 등을 게재하고 있습니다.·소개·조사방법·개요·개요·개요·프리미엄 인사이트 세계 항생제시장 마크로라이드, 아미노글리코시드), 세계 동물용 항생제·항균제 시장규모 : 전달방식별(프리믹스, 경구용액, 경구분말, 주사, 기타)·세계 동물용 항생제·항균제 시장규모 : 동물종류별(식료생산동물, 반려동물, 반려동물), 세계 동물용 항생제·항균제 시장규모 : 경쟁상황 ■항균제
“The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.”Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming yearsHowever, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.”The Tetracyclines segment accounted for the largest market share in 2020.”Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials and antibiotics market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users.”The Premixes segment accounted for the largest market share in 2020.”Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segmentor the largest share of 46.3% of the global animal antimicrobials and antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market.”The food producing animal segment accounted for the largest market share in 2020.”Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-prod companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.”North America was the largest regional market for animal antibiotics and antimicrobials market in 2020.”The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North Amted for the largest share of 30.3% of the global animal antimicrobials and antibiotics market. The large share of this region is mainly due to the increase in the region’s animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal po
■ 상품코드 : PH2458K ■ 조사 / 발행사 : Markets and Markets ■ 발행일 : 2021년 3월 ■ 쪽수 : 248 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : 이메일 ■ 조사 대상 지역 : 글로벌 ■ 산업 분야 : 제약 Markets and Markets and Markets사는 세계 동물용 항생제 및 항균제 및 항균제 형태 : PDF ■ 납품 방식 본 조사연구에서는 전 세계 동물용 항생제 및 항균제 시장을 광범위하게 조사, 소개, 조사방법, 개요, 프리미엄 인사이트, 시장개요, 산업인사이트, 제품별(테트라사이클린, 페니실린, 술파제, 마크로라이드, 아미노글리코시드) 분석, 전달방식별(프리믹스, 경구분말, 주사 기타) 분석, 동물 종류별(식량생산 동물, 페니실린, 마크로라이드, 펫트릭스에 관한 정보 등을 게재하고 있습니다.·소개·조사방법·개요·개요·개요·프리미엄 인사이트 세계 항생제시장 마크로라이드, 아미노글리코시드), 세계 동물용 항생제·항균제 시장규모 : 전달방식별(프리믹스, 경구용액, 경구분말, 주사, 기타)·세계 동물용 항생제·항균제 시장규모 : 동물종류별(식료생산동물, 반려동물, 반려동물), 세계 동물용 항생제·항균제 시장규모 : 경쟁상황 ■항균제
“The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.”Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming yearsHowever, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent.”The Tetracyclines segment accounted for the largest market share in 2020.”Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials and antibiotics market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users.”The Premixes segment accounted for the largest market share in 2020.”Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segmentor the largest share of 46.3% of the global animal antimicrobials and antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market.”The food producing animal segment accounted for the largest market share in 2020.”Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-prod companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.”North America was the largest regional market for animal antibiotics and antimicrobials market in 2020.”The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North Amted for the largest share of 30.3% of the global animal antimicrobials and antibiotics market. The large share of this region is mainly due to the increase in the region’s animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal po
